NKGen Biotech Inc. Common... (NKGN)
NASDAQ: NKGN
· Real-Time Price · USD
0.27
0.01 (3.85%)
At close: May 23, 2025, 2:39 PM
0.27
0.00%
After-hours: May 23, 2025, 02:39 PM EDT
3.85% (1D)
| Bid | 0.27 |
| Market Cap | 12.09M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -48.48M |
| EPS (ttm) | -2.27 |
| PE Ratio (ttm) | -0.12 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.3 |
| Volume | 7,960 |
| Avg. Volume (20D) | 463,679 |
| Open | 0.25 |
| Previous Close | 0.26 |
| Day's Range | 0.25 - 0.28 |
| 52-Week Range | 0.10 - 1.87 |
| Beta | 0.84 |
About NKGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NKGN
Website n/a
3 months ago
+27.12%
NKGen Biotech shares are trading higher after the ...
Unlock content with
Pro Subscription
3 months ago
+121.64%
NKGen Biotech shares are trading higher after the company received FDA Fast Track designation for Troculeucel for the treatment of moderate Alzheimer's disease.
